Friends Speciality Medicine Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 4.25 Cr
as on 23-10-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.30 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.04 Cr
as on 23-10-2024
- Revenue 15.81%
(FY 2023)
- Profit 2.74%
(FY 2023)
- Ebitda -24.95%
(FY 2023)
- Net Worth 51.75%
(FY 2023)
- Total Assets -7.78%
(FY 2023)
About Friends Speciality Medicine
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 4.25 Cr.
The company currently has active open charges totaling ₹7.30 Cr. The company has closed loans amounting to ₹3.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankush Sethi, Aarav Rawal, Raj Rawal, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PTC341744
- Company No.
341744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Friends Speciality Medicine Private Limited offer?
Friends Speciality Medicine Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Fitness Supplements, Surgical & ICU Equipments, Nebulizer Machine & Parts, Brain & Nervous System Drugs, Immunomodulator Drugs.
Who are the key members and board of directors at Friends Speciality Medicine?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankush Sethi  | Additional Director | 01-Aug-2024 | Current |
| Aarav Rawal | Additional Director | 01-Aug-2024 | Current |
| Raj Rawal | Director | 13-Nov-2018 | Current |
| Praveen Sethi | Director | 13-Nov-2018 | Current |
Financial Performance of Friends Speciality Medicine.
Friends Speciality Medicine Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.81% increase. The company also saw a slight improvement in profitability, with a 2.74% increase in profit. The company's net worth Soared by an impressive increase of 51.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Friends Speciality Medicine?
In 2023, Friends Speciality Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹7.30 Cr
₹3.04 Cr
Charges Breakdown by Lending Institutions
- Others : 7.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2020 | Others | ₹7.30 Cr | Open |
| 08 Mar 2022 | Others | ₹1.40 Cr | Satisfied |
| 08 Mar 2022 | Others | ₹1.64 Cr | Satisfied |
How Many Employees Work at Friends Speciality Medicine?
Friends Speciality Medicine has a workforce of 35 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Friends Speciality Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Friends Speciality Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.